Literature DB >> 32685047

ADRENAL ADENOMA WITH AUTONOMOUS CORTISOL SECRETION ACCOMPANIED BY HOMOLATERAL RENAL CELL CARCINOMA: A CASE REPORT.

C Liu1, H Zhang1, X Li1.   

Abstract

CONTEXT: Patients with renal malignancies present high risk of adrenal hyperplasia and adenoma, and part of these are primary lesions, mostly non-functional. Here we presented a case diagnosed as primary adrenal adenoma with autonomous cortisol secretion accompanied by homolateral renal cell carcinoma. CASE
PRESENTATION: A 79-year-old woman was referred for evaluation of a left adrenal mass, with a past medical history of severe hypertension, diabetes, and hyperlipidemia. On examination, no clinical signs of cushingoid features were found. Biochemical measurements showed plasma cortisol was 12.77 μg/dL and was not suppressed by 1 mg dexamethasone (DXM) overnight test (13.6 μg/dL). The contrast CT scan presented a 2.2 cm diameter adrenal mass and revealed, unfortunately, a hyperdense mass at the middle-upper pole of the left kidney. Laparoscopic nephrectomy with left adrenalectomy was performed and pathological examination indicated a final diagnosis of benign adrenocortical adenoma and renal clear cell carcinoma. At 2 months postoperatively, without replacement treatment of cortisol, a recovery of circadian rhythm of cortisol secretion was detected, indicated recovery of the hypothalamic-pituitary-adrenal axis.
CONCLUSIONS: Patients with renal cancer might be accompanied with functional adrenal adenoma. Therefore, screening for adrenal function should be recommended in patients with renal tumors and/or adrenal incidentaloma. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Subclinical Cushing’s syndrome; adrenal adenoma; adrenal incidentaloma; renal carcinoma

Year:  2020        PMID: 32685047      PMCID: PMC7364015          DOI: 10.4183/aeb.2020.97

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  19 in total

Review 1.  Subclinical hypercortisolism: a state, a syndrome, or a disease?

Authors:  Guido Di Dalmazi; Renato Pasquali; Felix Beuschlein; Martin Reincke
Journal:  Eur J Endocrinol       Date:  2015-08-17       Impact factor: 6.664

Review 2.  Subclinical hypercortisolism in adrenal incidentaloma.

Authors:  Miguel Debono; John Newell-Price
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

3.  Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas.

Authors:  Alexandra Chrisoulidou; Pantelitsa Rakitzi; Maria Boudina; Fani Apostolidou-Kiouti; Eirini Poimenidou; Achilleas Papanikolaou; Anastasia Devlioti; Grigorios Rallis; Kalliopi Pazaitou-Panayiotou
Journal:  Hormones (Athens)       Date:  2019-02-09       Impact factor: 2.885

4.  Increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas.

Authors:  Caixia Cao; Xuecheng Yang; Li Li; Ruixia Sun; Yuxin Xian; Wenshan Lv; Jing Wang; Yijun Xu; Yanyan Gao
Journal:  Int J Urol       Date:  2011-08-17       Impact factor: 3.369

5.  Adrenal incidentaloma: clinical characteristics and comparison between patients with and without extraadrenal malignancy.

Authors:  G Tsvetov; I Shimon; C Benbassat
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

6.  Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study.

Authors:  Giuseppe Reimondo; Elena Castellano; Maurizio Grosso; Roberto Priotto; Soraya Puglisi; Anna Pia; Micaela Pellegrino; Giorgio Borretta; Massimo Terzolo
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 7.  Subclinical Cushing's syndrome: current concepts and trends.

Authors:  George N Zografos; Iraklis Perysinakis; Evangeline Vassilatou
Journal:  Hormones (Athens)       Date:  2014 Jul-Sep       Impact factor: 2.885

8.  Adrenal adenoma associated with renal cell carcinoma.

Authors:  M A Ambos; M A Bosniak; R S Lefleur; H A Mitty
Journal:  AJR Am J Roentgenol       Date:  1981-01       Impact factor: 3.959

Review 9.  Subclinical Hypercortisolism: How to Deal with It?

Authors:  Iacopo Chiodini; Valentina Morelli
Journal:  Front Horm Res       Date:  2016-05-17       Impact factor: 2.606

10.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.